# Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System
> **Product code: PGX** · Class II — Moderate Risk (510(k) clearance required) · Microbiology · 21 CFR 866.2680
## Classification
- **FDA Product Code:** PGX
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 866.2680
- **Review panel:** MI
- **Medical specialty:** Microbiology
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Definition

An in vitro diagnostic test for the detection of Group A, C and G beta hemolytic Streptococcus in throat swab specimens from symptomatic patients.

## Market data
- **Cleared 510(k) submissions:** 13
- **Registered establishments:** 17
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=PGX)
---
*AI Analytics · CC0 1.0*